RANDOMIZED TRIAL OF COMBINED MODALITY THERAPY (5000 R + 5FU + MECCNU) VS COMBINATION CHEMOTHERAPY (5FU + MECCNU) IN TREATMENT OF LOCALLY ADVANCED GASTRIC CANCER

被引：0
|
作者：
LIVSTONE, EM [1 ]
机构：
[1] YALE UNIV,NEW HAVEN,CT 06520
来源：
GASTROENTEROLOGY | 1978年 / 74卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1057 / 1057
页数：1
相关论文
共 50 条
  • [1] CONTROLLED RANDOMIZED EVALUATION OF COMBINED MODALITY THERAPY (5000 RAD, 5-FU + MECCNU) VS 5-FU + MECCNU ALONE FOR LOCALLY UNRESECTABLE GASTRIC CANCER
    SCHEIN, PS
    CHILDS, D
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 329 - 329
  • [2] CONTROLLED RANDOMIZED EVALUATION OF COMBINED MODALITY THERAPY (5,000 R+5-FU + MECCNU VERSUS COMBINATION CHEMOTHERAPY (5-FU+MECCNU) IN TREATMENT OF LOCALLY UNRESECTABLE GASTRIC CARCINOMA
    LIVSTONE, EM
    [J]. DIGESTION, 1977, 16 (03) : 256 - 256
  • [3] Final results of a randomized phase III trial of docetaxel, carboplatin and 5FU versus epirubicin, cisplatin and 5FU for locally advanced gastric cancer
    Elsaid, AA
    Elkerm, Y
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 311S - 311S
  • [4] Interaction of 5FU chemotherapy and oncolytic adenovirus in combined cancer treatment
    Sell, Jordan
    Oliviera, Amanda
    Jensen, Eric
    Yamamoto, Masato
    Davydova, Julia
    [J]. CANCER RESEARCH, 2016, 76
  • [5] A role for levamisole (LEV) in the adjuvant treatment of stage III colon cancer: A randomized trial of 5-fluorouracil (5FU) and LEV vs 5FU alone
    Catalano, V
    Cascinu, S
    Latini, L
    Mattioli, R
    Marcellini, M
    Pancotti, A
    Bascioni, R
    Torresi, U
    Silva, RR
    Pieroni, V
    Giorgi, F
    Testa, I
    Sturba, F
    Ferretti, B
    Catalano, G
    Cellerino, R
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 66 - 66
  • [6] CYTOXAN (CTX) + METHOTREXATE (MTX) + 5FU VS L-PAM + MTX + 5FU IN THE TREATMENT OF ADVANCED BREAST-CANCER
    PLOTKIN, D
    OPFELL, R
    KATTLOVE, H
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 392 - 392
  • [7] Evaluating the Efficacy of Combination Cancer Treatment: Oncolytic Adenovirus and 5FU Chemotherapy
    Sell, Jordan
    Oliviera, Amanda
    Jensen, Eric
    Greeno, Edward
    Yamamoto, Masato
    Davydova, Julia
    [J]. MOLECULAR THERAPY, 2016, 24 : S167 - S167
  • [8] A randomized phase III trial of adjuvant radio - Chemotherapy comparing irinotecan (CPT-11), 5FU and leucovorin to 5FU and leucovorin in patients with rectal cancer
    Kalofonos, Haralabos P.
    Pentheroudakis, George
    Rigatos, Sotirios
    Papakostas, Pavlos
    Tsavdaridis, Dimitrios
    Xiros, Nikolaos
    Dimopoulos, Meletios A.
    Galani, Eleni
    Pectasides, Dimitrios
    Fountzilas, George
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 116 - 116
  • [9] Randomized phase III trial comparing 5FU bolus and low dose leucovorin versus 5FU bolus plus continuous 5FU infusion and high dose LV in metastatic colorectal cancer
    Bosset, JF
    DeGrammont, A
    Milan, C
    Rougier, P
    Bouche, O
    Etienne, PL
    Morvan, F
    Louvet, C
    Guillot, T
    Bedenne, L
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 702 - 702
  • [10] The use of palliative protracted infusion 5FU (PVI 5FU) as first line treatment for metastatic oesophageal and gastric cancer patients not suitable for standard cisplatin based combination treatment
    Abdul, Razak A.
    Fox, V
    Coxon, F.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : VII52 - VII52
12345